Even though they exhibited consistent tumor-normal dysregulation, five genes (COL12A1, CTSB, PLOD1, SPP1, and SULF1) were excluded from the final candidate list as they did not satisfy the meta-analysis criteria and exhibited loss of prognostic significance. The gene discussed is PLOD1; the disease is neoplasm.